Back to search
Sarcoidosis of the Heart
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Sarcoidosis of the Heart trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Sarcoidosis of the Heart trials you may qualify forThe goal of this observational study is to pursue a multimodal approach to identify the molecular signatures and immune signalling molecules of various myocardi…
What is this study about? This research is focused on improving the care for people with rare heart muscle diseases, known as rare cardiomyopathies. These are u…
Heart scarring, also known as fibrosis, plays a major role in a lot of heart muscle abnormalities. These abnormalities of the heart muscle can lead to major iss…
Cardiac damage is the second leading cause of death in patients with sarcoidosis, after lung damage. Today's challenge is to diagnose the disease as effectively…
Determining the etiology of cardiomyopathy is of high clinical importance for optimal treatment strategy and prediction of prognosis. There is increased risk fo…
Acute myocardial inflammation is an heterogenic syndrome involving different clinical pathologies with different outcome. For the purpose of this study protocol…
Autoimmune diseases affect a total of 5 to 10% of the population. These diseases are associated with an increased risk of developing cardiovascular pathologies.…
The aim of this study is to assess the impact of implementing a patient education and preparation protocol for FDG PET (18F-FDG PET) imaging on the quality of i…